
TELA Bio TELA
$ 0.92
-2.59%
Quarterly report 2026-Q1
added 05-13-2026
TELA Bio Interest Expense 2011-2026 | TELA
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense TELA Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.29 M | 1.42 M | 5.22 M | 4.05 M | 3.6 M | 3.56 M | 3.61 M | 1.8 M | 4.56 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.22 M | 1.29 M | 3.23 M |
Quarterly Interest Expense TELA Bio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 366 K | 152 K | 379 K | 479 K | - | 337 K | 301 K | 497 K | - | 558 K | 870 K | 1.25 M | - | 1.03 M | 934 K | 911 K | - | 922 K | 864 K | 889 K | - | 898 K | 884 K | 879 K | - | 899 K | 914 K | 912 K | - | 309 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.25 M | 152 K | 714 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.44 | 2.14 % | $ 324 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.24 | -0.06 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.33 | 1.88 % | $ 162 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 73.6 | -0.15 % | $ 4.01 B | ||
|
LENSAR
LNSR
|
636 K | $ 6.0 | 2.04 % | $ 71.7 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.32 | 0.47 % | $ 51.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 18.45 | -0.24 % | $ 433 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.44 | 1.87 % | $ 410 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.9 | -0.29 % | $ 209 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.6 | -5.15 % | $ 532 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.55 | 0.65 % | $ 63.1 M | ||
|
Electromed
ELMD
|
455 K | $ 38.75 | 2.49 % | $ 328 M | ||
|
Myomo
MYO
|
-668 K | $ 0.92 | 0.05 % | $ 38.5 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 4.45 | 1.14 % | $ 1.1 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.17 | -1.58 % | $ 6.02 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 10.15 | -16.46 % | $ 402 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 84.32 | 0.37 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 155.87 | -0.46 % | $ 11 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 68.0 | - | $ 2.31 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.74 | -0.77 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 43.99 | -0.36 % | $ 1.29 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 90.09 | -1.47 % | $ 3.13 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 82.89 | -0.12 % | $ 48.5 B |